10 Jefferies Group Alnylam Pharmaceuticals Trades
Jefferies Group acquired 15.3 Thousand Alnylam Pharmaceuticals shares worth $3.85 Million. That's 0.07% of their equity portfolio (244th largest holding). The first Alnylam Pharmaceuticals trade was made in Q4 2022. Since then Jefferies Group bought shares five more times and sold shares on four occasions. The investor's estimated purchase price is $3.94 Million, resulting in a loss of 2.1%.
News about Alnylam Pharmaceuticals Inc and Jefferies Group
Private Advisor Group LLC Has $377,000 Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Private Advisor Group LLC boosted its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) by 54.9% in the 2nd quarter, HoldingsChannel reports. The firm ...
FY2024 EPS Estimates for Alnylam Pharmaceuticals, Inc. Lowered by Jefferies Financial Group (NASDAQ:ALNY)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) – Research analysts at Jefferies Financial Group decreased their FY2024 earnings per share estimates for shares o...
Alnylam Receives Positive CHMP Opinion for OXLUMO™ (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 in All Age Groups
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the Committee fo...
Alnylam Pharma partners with Taiba Group to commercialize RNAi therapeutics in Gulf states (NASDAQ:ALNY)
Alnylam Pharmaceuticals (NASDAQ:ALNY) and Taiba Middle East, a rare disease company based in the UAE, have formed a Distribution Agreement for both Onpattr